A Surprising Vaccine Rival May Upset the Dreams of Anyone Holding Moderna and Pfizer Stock

Motley Fool2021-04-13

A small team of 10 researchers began designing vaccine candidates shortly after the genetic sequence of the SARS-CoV-2 virus was made public last January. For the past decade, the team had worked on ...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
7